Home › Funds › PERCEPTIVE ADVISORS LLC › EWTX

PERCEPTIVE ADVISORS LLC position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

PERCEPTIVE ADVISORS LLC reported holding 4,373,974 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$177.7M, representing 2.82% of its reported portfolio and ranking #10 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed EWTX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)4.37M sh
Reported value held$177.71M
Portfolio Weight2.82%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PERCEPTIVE ADVISORS LLC's EWTX position evolved

PERCEPTIVE ADVISORS LLC first disclosed a stake in EWTX in Q4 2023 at 555,555 shares (US$6.1M). The position peaked in Q2 2026 at 4,373,974 shares, worth US$177.7M. Across 11 filings, PERCEPTIVE ADVISORS LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,373,974 shares valued at US$177.7M — a reduction of -50,000 shares quarter over quarter.. Notable position changes include a 318% increase in Q1 2024 (shares fell 1% over the following quarter), a 81% trim in Q1 2025 (shares fell 40% over the following quarter), a 828% increase in Q2 2025 (shares rose 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 555.55K $6.08M New
Q1 2024 2.32M $42.31M Add
Q2 2024 1.86M $33.43M Reduce
Q3 2024 2.33M $62.20M Add
Q4 2024 2.69M $71.70M Add
Q1 2025 500.00K $11.00M Reduce
Q2 2025 4.64M $60.83M Add
Q3 2025 3.80M $61.57M Reduce
Q4 2025 4.46M $110.62M Add
Q1 2026 4.42M $139.36M Reduce
Q2 2026 4.37M $177.71M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has PERCEPTIVE ADVISORS LLC held EWTX?

PERCEPTIVE ADVISORS LLC has disclosed EWTX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is PERCEPTIVE ADVISORS LLC's current position in EWTX?

As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 4.37M shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $177.71M, representing 2.82% of its reported portfolio and ranking #10.

Has PERCEPTIVE ADVISORS LLC been buying or selling EWTX?

In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC reduced its position in EWTX. The position peaked in Q2 2026 at 4.37M shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.